Back

Newly developed atrial fibrillation is an unfavorable sign of anthracycline-induced cardiomyopathy

28 August 2016 (16:10 - 16:17)
Organised by:
Congress Presentation Part of: Cardio-oncology Cardiotoxicity of drugs ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Michitaka Amioka

Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima (Japan)

6 More presentations in this session

Presentation thumbnail
Myocardial copper and iron content in failing human heart: the implications for mitochondrial function
Doctor V. Melenovsky (Prague, CZ)
Abstract Slides
Presentation thumbnail
Prevalence and functional significance of cardiac autonomic dysfunction among women with breast cancer
Doctor J. Groarke (Boston, US)
Abstract Slides
Presentation thumbnail
Global and regional patterns of longitudinal deformation imaging in the monitoring of chemotherapy-induced cardiotoxicity
Doctor G. Portugal (Lisbon, PT)
Abstract Slides
Presentation thumbnail
4D deformation, arterial stiffness, and cardiac biomarkers for the early detection of chemotherapy-induced cardiotoxicity in patients with nonHodgkin lymphoma
Doctor D. Mihalcea (Bucharest, RO)
Abstract Slides
Presentation thumbnail
Left ventricular end-diastolic volume as an early indicator of Trastuzumab-related cardiotoxicity in patients with HER2 positive breast cancer: results from a single-center retrospective study
Doctor F. Torelli (Verona, IT)
Abstract Slides

Access the full session

Session thumbnail
Cardio-oncology

The Event

Event poster

ESC Congress 2016

28 August 2016 16:10 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources